Welcome to LookChem.com Sign In|Join Free
  • or
AKOS BBS-00006125 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

210360-63-7

Post Buying Request

210360-63-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

210360-63-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 210360-63-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,0,3,6 and 0 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 210360-63:
(8*2)+(7*1)+(6*0)+(5*3)+(4*6)+(3*0)+(2*6)+(1*3)=77
77 % 10 = 7
So 210360-63-7 is a valid CAS Registry Number.

210360-63-7Downstream Products

210360-63-7Relevant academic research and scientific papers

Synthesis of anabasine-containing aminomethyl derivatives of 6-hydroxyaurones

Popova, Antonina V.,Bondarenko, Svitlana P.,Vinogradova, Valentina I.,Frasinyuk, Mykhaylo S.

, p. 212 - 216 (2019/05/15)

[Figure not available: see fulltext.] Aminomethylation of aurones was studied by using anabasine. The reaction in the case of 6-hydroxyaurones was shown to selectively provide 7-aminomethyl-6-hydroxyaurones, while 5-aminomethyl-6-hydroxy-7-methylaurones could be obtained by transamination of 5-dimethylaminomethyl derivatives of 6-hydroxy-7-methylaurones in the presence of anabasine.

Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors

Lee, Young Hun,Shin, Min Cheol,Yun, Yong Don,Shin, Seo Young,Kim, Jong Min,Seo, Jeong Moo,Kim, Nam-Jung,Ryu, Jong Hoon,Lee, Yong Sup

, p. 231 - 240 (2015/02/18)

Alzheimer's disease (AD), a progressive and neurodegenerative disorder of the brain, is the most common cause of dementia among elderly people. To date, the successful therapeutic strategy to treat AD is maintaining the levels of acetylcholine by inhibiting acetylcholinesterase (AChE). In the present study, aurone derivatives were designed and synthesized as AChE inhibitors based on the lead structure of sulfuretin. Of those synthesized, compound 10d showed ca. 1700-fold and 6-fold higher AChE inhibitory activity than sulfuretin and galantamine, respectively. This compound also ameliorated scopolamine-induced memory deficit in mice when administered orally at the dose of 1 and 2 mg/kg.

Benzofuranone derivatives and a method for producing them

-

, (2008/06/13)

PCT No. PCT/JP98/00090 Sec. 371 Date Dec. 7, 1998 Sec. 102(e) Date Dec. 7, 1998 PCT Filed Jan. 13, 1998 PCT Pub. No. WO98/30556 PCT Pub. Date Jul. 16, 1998The present invention provides new benzofuranone derivatives and a method for producing the derivatives useful for a therapeutic agent for preventing and/or treating hormone dependent diseases. The present invention is a new benzofuranone derivative represented by a particular general formula (I). In the production, a particular benzofuranone compound and a particular benzaldehyde are reacted.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 210360-63-7